MABS SPECIFIC TO SEROTONIN 5-HT RECEPTORS
MABS SPECIFIC TO SEROTONIN 5-HT RECEPTORS
批准号:
2714272
负责人:
SUJAY K SINGH
金额:
$39.76万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-11-01 至 2000-08-31
中文摘要
5-羟色胺(5-羟色胺;5-HT)介导许多中枢和
英文摘要
Serotonin (5-hydroxytryptamine; 5-HT) mediates many central and
peripheral nervous functions by its interaction with specific neuronal
receptors. The 5-HT receptors are implicated in various normal
physiological responses, e.g., smooth muscle contraction, platelet
aggregation, aldosterone production, circadian rhythm, and neuronal
development and various disorders such as migraine headaches, anxiety,
mental depression, and undesired behavior. 5-HT receptors are also
binding sites for hallucinogenic drugs. At least sixteen serotonin
receptors belonging to seven subtypes have been identified. A better
understanding of the localization (the sites of action) and regulation
of 5-HT receptors may lead to development of receptor specific drugs.
Through SBIR Phase I funding, we have developed monoclonal antibodies
that are highly specific to the three members of the 5-HT2 receptor
family. As a continuation of this project, we proposed to generate
monoclonal antibodies to the rest of the 5-HT receptors. Antibodies will
be screened for their utility in immunohistochemistry, western blot, and
immunoprecipitation. We also propose to develop molecular probes for
detection and quantitation of 5-HT receptors by PCR and RNase protection
assay. The combination of monoclonal antibodies and the probes for PCR
and RNase protection assay will provide powerful research tools for
fundamental and applied serotonin receptor research.
PROPOSED COMMERCIAL APPLICATIONS:
The result of this study will provide tools, which can be readily
commercialized as research reagents. At present monoclonal antibodies to
5-HTRs (other than to 5-HT2 receptor developed by us) and RNase
protection assay probes are not available. Since the field of serotonin
research field is large and more than 27,000 articles with potential
significance for clinical application have been published in the last ten
years, we predict the market to be of a reasonable size.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibitors of RANK and RANKL in Osteoporosis Treatment
-
批准号:6484987
-
项目类别:
-
资助金额:$8.95万
-
财政年份:2003
-
负责人:SUJAY K SINGH
-
依托单位:
Improved Vectors for Gene Silencing in Mammalian Cells
-
批准号:6645752
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2003
-
负责人:SUJAY K SINGH
-
依托单位:
Monoclonal Antibodies to GABA Metabolic Pathway Proteins
-
批准号:6549622
-
项目类别:
-
资助金额:$9.99万
-
财政年份:2002
-
负责人:SUJAY K SINGH
-
依托单位:
Generation of T7 RNA Polymerase Transgenic Mouse Strain
-
批准号:6484294
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2002
-
负责人:SUJAY K SINGH
-
依托单位:
Monoclonal Antibodies for Osteoporosis Research
-
批准号:6549407
-
项目类别:
-
资助金额:$36.54万
-
财政年份:2002
-
负责人:SUJAY K SINGH
-
依托单位:
MONOCLONAL ANTIBODIES FOR OSTEOPOROSIS RESEARCH
-
批准号:6141982
-
项目类别:
-
资助金额:$9.96万
-
财政年份:2000
-
负责人:SUJAY K SINGH
-
依托单位:
MABS SPECIFIC TO METABOTROPIC GLUTAMATE RECEPTORS
-
批准号:2625765
-
项目类别:
-
资助金额:$9.98万
-
财政年份:1997
-
负责人:SUJAY K SINGH
-
依托单位:
MABS SPECIFIC TO SEROTONIN 5HT2 RECEPTORS
-
批准号:2254803
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1995
-
负责人:SUJAY K SINGH
-
依托单位:
MABS SPECIFIC TO SEROTONIN 5-HT RECEPTORS
-
批准号:2890698
-
项目类别:
-
资助金额:$33.92万
-
财政年份:1995
-
负责人:SUJAY K SINGH
-
依托单位:
海外基金